benzamide has been researched along with isocarbostyril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camaioni, E; Costantino, G; Macchiarulo, A; Pellicciari, R | 1 |
| Bozarth, JM; Cheney, DL; Metzler, WJ; Morin, PE; Mueller, L; Newitt, JA; Nirschl, AH; Priestley, ES; Rendina, AR; Seiffert, DA; Tamura, JK; Wei, A; Wen, X; Wexler, RR; Wurtz, NR | 1 |
2 other study(ies) available for benzamide and isocarbostyril
| Article | Year |
|---|---|
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
Topics: Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Ligands; Models, Molecular; Naphthalenes; Phenanthridines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Binding; Quantitative Structure-Activity Relationship; Quinazolines | 2001 |
Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening.
Topics: Blood Coagulation; Crystallography, X-Ray; Drug Design; Factor VIIa; Halogens; Heterocyclic Compounds; Humans; Lactams; Models, Molecular; Molecular Docking Simulation; Serine Proteinase Inhibitors | 2015 |